接种剂效应对塞费皮姆对AMPC过度产生的Enterobacter spp.活性的影响. : 对抗性机制的洞察力
Ángel Rodríguez-Villodres1,2,3, Carmen Soto-Gallego1,2, José Manuel Ortiz De La Rosa1,2,3
1Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain.
The Journal of antimicrobial chemotherapy
|April 23, 2025
概括
较高的细菌负载显著降低了cefepime对AMPC过度生产的Enterobacter spp.的有效性. 通过增加阻力. 这需要量身定制的抗微生物策略,以获得更好的患者结果.
科学领域:
- 临床微生物学 临床微生物学
- 传染病 传染病 传染病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 在Enterobacter spp.中的抗微生物耐药性. 由于AmpCβ-乳糖酶的过度生产,这是一个主要的医疗保健问题.
- 由于高的细菌负载,Cefepime的有效性可能会受到损害.
研究的目的:
- 评估细菌注射剂大小对塞菲皮姆对抗AMPC过度生成的Enterobacter spp.活性的影响. 临床分离物.临床分离物.
主要方法:
- 最低抑制度 (MIC) 用标准和高注射剂的微稀释来确定.
- 进行了卡普兰-梅尔生存分析,时间杀戮测试和测量β-乳酸酶活性.
主要成果:
- 高注射剂显著增加了塞费皮姆的MIC (MIC50: 8 mg/L,MIC90: 256 mg/L) 和耐药率 (从6.5%到54.8%).
- 在61.3%的隔离物中观察到注射剂效应,与更高的β-乳酸酶活性和cefepime水解有关.
结论:
- 细菌注射体的大小对AmpC过度生成的Enterobacter spp.中的cefepime疗效产生了重大影响. 感染. 感染.
- 优化的抗微生物策略对于高细菌负载感染至关重要,以改善结果和对抗耐药性.
更多相关视频
相关概念视频
Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


